Week 3 HW: Cell-Free Reaction Design

Part A: Compare Cell-Free Reaction Compositions

1. Why do potassium glutamate and magnesium glutamate concentrations differ between compositions? Which is more sensitive?

Potassium glutamate and magnesium glutamate are both essential for cell-free protein synthesis (CFPS), but they serve different biochemical roles and their optimal concentrations depend on the formulation’s goals.

Potassium glutamate primarily maintains ionic strength and provides glutamate as the preferred anion. Glutamate is superior to chloride because it better mimics the E. coli cytoplasmic environment, supports long-lived protein synthesis, and can serve as a nitrogen source. Concentrations typically range from 80 mM to 200 mM. High concentrations (e.g., 200 mM in PANOx) support rapid, high-yield synthesis, while lower concentrations (e.g., 130 mM in Cytomim) are used when mimicking the cytoplasm or reducing cost.

Magnesium glutamate is a critical cofactor for T7 RNA polymerase, ribosome assembly, and nucleotide binding. It is required for the catalytic activity of many enzymes in transcription and translation. Magnesium concentration is highly sensitive: too little leads to inactive ribosomes and polymerase; too much causes non-specific binding and inhibition. Formulations often optimize magnesium separately (e.g., 1–6 mM) while keeping potassium glutamate fixed at a mean concentration.

Which is more sensitive? Magnesium is generally more sensitive. Small changes in Mg²⁺ (1–2 mM) can drastically alter transcription and translation efficiency. Potassium glutamate can be varied over a wider range (80–200 mM) with less dramatic effects, though it still influences yield. The literature notes that magnesium glutamate is often sequentially optimized, while potassium glutamate is set at a mean value, indicating that magnesium requires finer tuning.

Why concentrations differ: Different formulations have different objectives. PANOx maximizes yield and uses 200 mM potassium glutamate and 0 mM magnesium glutamate (relying on other magnesium sources). Cytomim aims to mimic the cytoplasmic environment and uses 130 mM potassium glutamate and 8 mM magnesium glutamate. Cost-optimized formulations may reduce both to lower reagent expenses.

2. Explain how a PEP+NTP reaction formulation is different from a Ribose+NMP reaction formulation.

A PEP+NTP formulation uses phosphoenolpyruvate (PEP) as the primary energy source and nucleotide triphosphates (NTPs: ATP, GTP, CTP, UTP) as direct building blocks for RNA synthesis.

• PEP regenerates ATP from ADP via pyruvate kinase. It provides a high-energy phosphate bond, but its metabolism produces a rapid and sustained increase in inorganic phosphate, which can inhibit protein synthesis over time by precipitating magnesium and interfering with enzyme function.
• NTPs are added directly, so they do not require phosphorylation. This is convenient but expensive because NTPs are costly to synthesize and purify.

A Ribose+NMP formulation, by contrast, would use ribose as a carbon and energy source and nucleotide monophosphates (NMPs) as precursors.

• Ribose can enter glycolysis or the pentose phosphate pathway to generate ATP and reducing equivalents.
• NMPs must be phosphorylated to NTPs, consuming ATP. This requires additional enzymatic steps (e.g., nucleoside monophosphate kinases, nucleoside diphosphate kinases). This approach is less common because it is less efficient and more complex, but it could reduce cost if NMPs are cheaper than NTPs.

In practice, most CFPS systems use NTPs directly or alternative energy sources like pyruvate, maltose, or maltodextrin. The term “Ribose+NMP” is not standard in the literature; it may refer to a hypothetical or specialized formulation. The key difference is that PEP+NTP provides energy and building blocks separately, while Ribose+NMP would rely on cellular metabolism to convert precursors into energy and nucleotides, potentially reducing reagent costs but increasing metabolic burden.

3. Choose two cell-free reaction compositions from the literature, compare and contrast the choice of reagents and the concentration of reagents.

I compare the PANOx system and the Cytomim system, both well-characterized in the literature.

Comparison of energy substrates: PANOx uses PEP, which provides a burst of ATP but leads to phosphate accumulation and pH drop. Cytomim uses sodium pyruvate, which is metabolized more slowly, producing more stable pH and lower phosphate levels. This makes Cytomim better for long reactions.

Comparison of salts: PANOx relies on a very high potassium glutamate concentration (200 mM) and no magnesium glutamate. Cytomim balances potassium (130 mM) and magnesium (8 mM) glutamate to better mimic the cytoplasmic environment. It also includes ammonium glutamate (10 mM), which PANOx lacks.

Comparison of buffering: PANOx uses HEPES-KOH (57 mM) for buffering, while Cytomim uses Tris (2.4 mM). HEPES is a good buffer for CFPS but is more expensive. Tris is cheaper but can react with certain components.

Comparison of additives: PANOx includes 2% PEG, which can enhance protein folding and prevent aggregation. Cytomim includes a higher concentration of sodium oxalate (4 mM vs 2.7 mM), which may influence energy metabolism.

Contrast: The main differences stem from the choice of energy substrate. PANOx is optimized for high yield in short reactions, while Cytomim is designed for longer-lived reactions with better pH stability. The salt composition reflects these goals: PANOx uses high glutamate to support rapid synthesis, while Cytomim uses a more balanced salt profile to mimic the cytoplasm.

Part B: Design One Reaction Composition for Each Protein

Fixed Components (9,000 nL total)

Variable Components (11,000 nL total)

Each variable component must be specified in multiples of 25 nL. The sum of all variable volumes must be exactly 11,000 nL. Any remaining volume is filled with nuclease-free water.

1. sfGFP – Reducing Condition

Justification: sfGFP is a robust, well-folded protein with no disulfide bonds. Its two cysteines remain as free thiols. A standard reducing environment with DTT in the lysate is sufficient. This composition provides ample energy, salts, and cofactors for high-yield expression. sfGFP serves as the baseline control to confirm the reaction is functioning.

2. PETase – Reducing Condition

Justification: PETase is a serine hydrolase from Thermobifida fusca with a catalytic triad (Ser170, Asp216, His248) and one disulfide bond. Unlike Reteplase, this single disulfide bond can form correctly in the presence of the lysate’s natural oxidoreductases. The reducing condition maintains free thiols and prevents aggregation. Using the same formulation as sfGFP reduces reagent inventory and simplifies the screening workflow. If PETase activity is low, a mild oxidizing condition with low GSSG could be tested.

3. Reteplase – Oxidizing / DSB Condition

Justification: Reteplase is a 355-amino-acid therapeutic derived from human tPA with nine disulfide bonds that must pair correctly for activity. It cannot fold in a reducing environment. Three modifications are required:

1. Modified lysate: Prepared without DTT, treated with iodoacetamide (IAM) to cap free thiols, then quenched with cysteine. This prevents the lysate from reducing newly formed disulfide bonds.
2. Redox buffer: GSSG/GSH in a controlled ratio to establish an oxidizing environment. The ratio can be tuned (e.g., 2:1, 4:1, 8:1) to optimize folding.
3. Folding helper: DsbC, a disulfide-bond isomerase, to rearrange incorrectly paired disulfide bonds. Lysate from a Δgor strain preserves the oxidizing environment.

Community Reagent Contribution

Reagent proposed: Trehalose

Rationale:
Trehalose is a non-reducing disaccharide that stabilizes proteins and prevents aggregation. It acts as a chemical chaperone, helping proteins maintain solubility during translation and reducing inclusion body formation. For Reteplase, which is prone to misfolding, trehalose could improve the yield of active protein. It is cheap, safe, and compatible with CFPS. Literature suggests that trehalose can enhance CFPS yields by stabilizing the translation machinery and promoting proper folding.

How I decided: I looked for additives that improve folding of disulfide-bonded proteins. Trehalose is widely used in biopreservation and has been tested in CFPS. It is a low-cost reagent with high potential impact, especially for the DSB formulation required by Reteplase.

Relevant literature:

• Search: https://scholar.google.com/scholar?q=trehalose+cell-free+protein+synthesis+protein+folding
• Example study: “Trehalose enhances cell-free protein synthesis by stabilizing the translation machinery” (verify exact citation).

Forum Participation

Post to CFPS coopetition forum:

Optimization idea for Reteplase:
I’d like to share an idea for optimizing the CFPS formulation for Reteplase, which is the most challenging target due to its nine required disulfide bonds.

My proposal is to test a matrix of conditions specifically focused on improving the yield of correctly folded, active protein. Instead of testing a single variable, I suggest we screen a combination of the following factors:

Redox Buffer Ratio: Test a matrix of different GSSG:GSH ratios (e.g., 2:1, 4:1, and 8:1) to find the optimal oxidizing environment that favors disulfide bond formation without causing over-oxidation.

Folding Helper Concentration: Vary the concentration of the disulfide-bond isomerase DsbC (e.g., 0 nL, 250 nL, and 500 nL). DsbC is crucial for rearranging incorrectly paired disulfide bonds into their native, active conformation.

Incubation Temperature: Include a lower incubation temperature of 25°C in the screen, in addition to the standard 30°C. Slower translation and folding at a lower temperature can often improve the yield of complex, multi-disulfide-bonded proteins by reducing the formation of inactive inclusion bodies.

By testing these conditions in a combinatorial matrix, we can identify a formulation that significantly increases the yield of active Reteplase and provides a more robust, general strategy for producing other difficult-to-fold proteins in our CFPS system.

Looking forward to hearing your thoughts!

Part C: Asimov Kernel (Optional)

I built T7-compatible plasmids for cell-free expression of sfGFP, PETase, and Reteplase using Kernel. Each construct contains:

• T7 promoter
• RBS (BBa_B0034)
• Codon-optimized CDS for E. coli
• T7 terminator
• pET backbone

Bonus helper plasmid:
I designed a T7 helper plasmid co-expressing DsbC and chaperones GroEL/ES, DnaK/J/GrpE to improve folding of Reteplase. This plasmid can be added to the CFPS reaction to enhance disulfide bond formation and protein solubility.

AI Citation

AI client: DeepSeek
Prompts used:

• “Help me design CFPS compositions for sfGFP, PETase, and Reteplase, with volumes summing to 11,000 nL and biological justifications.”
• “Write a forum post idea about optimizing Reteplase.”
• “Generate the complete document in Markdown with tables and explanations.”

All biological decisions, volume calculations, and reagent choices were verified and adjusted by me.